ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2439

Knee Joint Pathology in Patients with Rheumatoid Arthritis and Osteoarthritis Using a Validated Ultrasound Scoring System: A Cross Sectional Study

Karen Ellegaard1, Marius Henriksen2, Birgit Falk Riecke3, Søren Just4, Jakob Espesen5, Mohammed Yusuf Naderi6 and Henning Bliddal3, 1Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, Frederiksberg, Denmark, 2Department of Rheumatology, The Parker Institute, Copenhagen University Hospital at Frederiksberg, Copenhagen F, Denmark, 3The Parker Institute, Copenhagen, Denmark, 4Department of Rheumatology, Svenborg Sygehus, Svendbotg, Denmark, 5Odense Universitetshospital, Odense, Denmark, 6Department of Rheumatology, Esbjerg Sygehus, Esbjerg, Denmark

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis, rheumatoid arthritis (RA) and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects (ARHP): Clinical Practice/Patient Care

Session Type: Abstract Submissions (ARHP)

Background/Purpose

Ultrasound (US) signs of inflammation in joints are synovial hypertrophy, effusion, and Doppler activity (increased perfusion), which have been demonstrated in both osteoarthritis (OA) and rheumatoid arthritis (RA).  It might be expected that inflammatory signs are more pronounced in patients with RA however, a comparison of RA and OA with respect to US changes remains to be performed. 

Methods

A standardized US examination and scoring technique in patients with OA has been developed and validated in a group of patients with knee OA. This validated technique was applied on a group of RA patients and a group of OA patients – both with knee involvement. The diagnoses of OA and RA were according to the ACR criteria. RA and OA patients were examined by US according to the standardized procedure at baseline before onset of biologics. In the present study the validated US scoring were performed in all patients (RA and OA).  All US images were scored by the same person (KE).  The amount of synovial hypertrophy (mm) and Doppler (+/- scored as 1/0) were measured in five positions (supra patellar; medial and lateral joint space and recess). Synovial hypertrophy measures for all 5 positions were summed and Doppler presence was summed for the medial and lateral joint space and recess (4 positions). Presence and size of Baker`s cyst were registered and any Doppler activity in or around the cyst was registered. Statistics: The difference between US findings in the two diseases was evaluated with both non-parametric and parametric statistics. The level of significance was 2α=0.05.

Results

Eighteen RA patients were included, the percentage of women was 66% and mean age was 66 years (range26.3-73). The mean DAS28 was 4.9 (range 3.5-7.0). The OA group consisted of 99 patients the percentage of women was 59 and the mean age was 64 (range42.3-84.4). See table

Conclusion

On US examination statistically significantly more synovial hypertrophy and more Baker`s cysts were seen in the OA knees as compared to the RA knees. Little Doppler activity (increased blood flow) was found with no difference between the two patient groups. These results support that inflammation is an important pathological feature in OA.

Acknowledgement: the study was supported by an unrestricted grant from Pfizer, Cambridge Weight Plan and the Oak Foundation.

 

OA (n=99)

Median [IQ]

mean (SD)

RA (n=18)

Median [IQ]

mean (SD)

p-value

(t-test)

p-value (Wilcoxon)

Synovial

hypertrophy (mm)

21.8 [17.1;27]

24.54(11.91)

14.35 (14.12;6.0)

[11.6; 20.2]

<0.0001

<0.0001

Baker`s cyst (0-12)

 

0 [0; 5]

2.19(2.52)

0 [0; 0]

0.24(0.66)

<0.0001

0.0044

Doppler (0-7)

 

0 [0;1]

0,69(1,18)

0 [0;1]

0.67(0.97)

0.94

0.80


Disclosure:

K. Ellegaard,
None;

M. Henriksen,
None;

B. F. Riecke,
None;

S. Just,
None;

J. Espesen,
None;

M. Y. Naderi,
None;

H. Bliddal,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/knee-joint-pathology-in-patients-with-rheumatoid-arthritis-and-osteoarthritis-using-a-validated-ultrasound-scoring-system-a-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology